Emergent peer-reviewed studies have highlighted the occurrence of neuromyelitis optica after COVID-19 vaccinations, suggesting that the autoimmune disease may be occurring as a vaccine adverse event.
The studies’ general findings indicate an occurrence of neuromyelitis optica (NMO) in healthy individuals within around two weeks after Pfizer, Moderna, and AstraZeneca vaccines. In patients already affected by the disease or a similar neurological autoimmune disease such as multiple sclerosis, an exacerbation of symptoms or relapse was observed.
